SurModics Company Profile (NASDAQ:SRDX)

About SurModics

SurModics logoSurModics, Inc. is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company is focused on to transform its medical device business from being a provider of coating technologies to offering whole product solutions to medical device customers. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device. The Company's In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. Its products include BioFX Liquid Nova-Stop Solution, StabilZyme Protein-Free AP Stabilizer, StabilZyme Protein-Free Stabilizer and StabilBlot Blocker Family.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: SRDX
  • CUSIP: 86887310
Key Metrics:
  • Previous Close: $26.65
  • 50 Day Moving Average: $28.86
  • 200 Day Moving Average: $25.43
  • 52-Week Range: $17.45 - $30.75
  • Trailing P/E Ratio: 38.79
  • Foreward P/E Ratio: 33.73
  • P/E Growth: 1.81
  • Market Cap: $338.52M
  • Outstanding Shares: 13,045,000
  • Beta: 0.97
  • Net Margins: 14.45%
  • Return on Equity: 17.11%
  • Return on Assets: 14.45%
  • Current Ratio: 6.71%
  • Quick Ratio: 6.29%
Additional Links:
Companies Related to SurModics:

Analyst Ratings

Consensus Ratings for SurModics (NASDAQ:SRDX) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $31.50 (18.20% upside)

Analysts' Ratings History for SurModics (NASDAQ:SRDX)
DateFirmActionRatingPrice TargetDetails
10/6/2016SidotiDowngradeBuy -> Neutral$33.00View Rating Details
5/3/2016Barrington ResearchBoost Price TargetOutperform$27.00 -> $30.00View Rating Details
3/27/2015Dougherty & CoInitiated CoverageBuy$33.00View Rating Details
(Data available from 10/26/2014 forward)


Earnings History for SurModics (NASDAQ:SRDX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/28/2016Q316$0.12$0.37$16.31 million$19.97 millionViewListenView Earnings Details
5/2/2016Q2$0.09$0.20$16.70 millionViewListenView Earnings Details
1/28/2016Q116$0.17$0.38$14.58 million$16.50 millionViewListenView Earnings Details
11/10/2015Q415$0.19$0.30$15.30 million$17.40 millionViewListenView Earnings Details
8/5/2015Q315$0.21$0.26$14.86 million$15.90 millionViewListenView Earnings Details
4/30/2015Q2$0.20$0.19$14.09 million$14.40 millionViewListenView Earnings Details
1/29/2015Q414$0.21$0.25$14.30 million$14.20 millionViewListenView Earnings Details
11/6/2014Q314$0.25$0.26$14.90 million$15.30 millionViewN/AView Earnings Details
7/31/2014Q214$0.23$0.27$14.84 million$14.62 millionViewListenView Earnings Details
5/1/2014Q114$0.20$0.22$14.40 million$13.60 millionViewListenView Earnings Details
1/30/2014Q413$0.21$0.21$14.15 million$13.90 millionViewListenView Earnings Details
11/5/2013Q313$0.22$0.26$14.32 million$14.30 millionViewListenView Earnings Details
7/31/2013Q3 2013$0.21$0.22$15.03 million$14.29 millionViewListenView Earnings Details
5/7/2013Q2 2013$0.21$0.20$13.92 million$13.70 millionViewListenView Earnings Details
1/30/2013Q1 2013$0.18$0.29$13.63 million$13.85 millionViewListenView Earnings Details
11/6/2012Q412$0.17$0.17$13.83 million$13.80 millionViewN/AView Earnings Details
8/1/2012$0.14$0.17ViewN/AView Earnings Details
5/8/2012$0.15$0.14ViewN/AView Earnings Details
11/3/2011$0.05$0.06ViewN/AView Earnings Details
8/3/2011$0.04$0.13ViewN/AView Earnings Details
4/27/2011$0.08ViewN/AView Earnings Details
1/26/2011$0.05ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for SurModics (NASDAQ:SRDX)
Current Year EPS Consensus Estimate: $1.04 EPS
Next Year EPS Consensus Estimate: $0.79 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.06$0.21$0.13
Q2 20163$0.09$0.17$0.12
Q3 20162$0.12$0.19$0.16
Q4 20161$0.10$0.10$0.10
(Data provided by Zacks Investment Research)


Dividend History for SurModics (NASDAQ:SRDX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for SurModics (NASDAQ:SRDX)
Insider Ownership Percentage: 7.20%
Institutional Ownership Percentage: 86.67%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/3/2016Gary R. MaharajCEOSell5,000$29.55$147,750.00View SEC Filing  
8/17/2016Charles W OlsonVPSell9,936$28.98$287,945.28View SEC Filing  
8/15/2016Susan E. KnightDirectorSell1,548$28.64$44,334.72View SEC Filing  
8/1/2016Charles W OlsonVPSell12,500$27.08$338,500.00View SEC Filing  
6/14/2016Bryan K PhillipsSVPSell1,816$23.44$42,567.04View SEC Filing  
6/10/2016Joseph J StichVPSell1,000$23.33$23,330.00View SEC Filing  
5/27/2016Susan E KnightDirectorSell1,001$22.71$22,732.71View SEC Filing  
3/4/2016Timothy J ArensVPSell10,291$18.43$189,663.13View SEC Filing  
12/4/2015Joseph J StichVPSell1,000$21.18$21,180.00View SEC Filing  
9/4/2015Joseph J StichVPSell1,000$23.57$23,570.00View SEC Filing  
6/5/2015Joseph J StichVPSell1,000$23.84$23,840.00View SEC Filing  
5/22/2015Bryan K PhillipsSVPSell7,293$25.25$184,148.25View SEC Filing  
12/29/2014Charles W OlsonVPSell5,083$21.98$111,724.34View SEC Filing  
12/8/2014Charles W OlsonVPSell3,365$21.66$72,885.90View SEC Filing  
11/19/2014Timothy J ArensVPSell10,330$21.02$217,136.60View SEC Filing  
5/8/2014Susan KnightDirectorBuy1,500$20.36$30,540.00View SEC Filing  
12/4/2013Bryan PhillipsSVPSell16,236$22.95$372,616.20View SEC Filing  
5/15/2013Mark A LehmanInsiderSell1,693$26.55$44,949.15View SEC Filing  
8/10/2012Value Lp StarboardMajor ShareholderSell257,560$17.74$4,569,114.40View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for SurModics (NASDAQ:SRDX)
DateHeadline logoSurModics, Inc. breached its 50 day moving average in a Bearish Manner : SRDX-US : October 14, 2016 (NASDAQ:SRDX) - October 14 at 10:44 AM logoUptrend Call Working As SurModics Stock Rises 43.5% (SRDX) (NASDAQ:SRDX) - October 12 at 7:25 PM logoSurmodics downgraded by Sidoti (NASDAQ:SRDX) - October 6 at 7:09 PM logo43.1% Return Seen to Date on SmarTrend SurModics Call (SRDX) (NASDAQ:SRDX) - September 27 at 7:22 PM logoSurmodics Inc (SRDX.O) (NASDAQ:SRDX) - September 23 at 11:49 AM logo39.8% Return Seen to Date on SmarTrend SurModics Call (SRDX) (NASDAQ:SRDX) - September 20 at 10:59 AM
News IconNew Report Available: Russia's ICT Spends in Telecommunications Sector - Future Perspective to 2019 (NASDAQ:SRDX) - September 15 at 11:06 AM logo36.9% Return Seen to Date on SmarTrend SurModics Call (SRDX) (NASDAQ:SRDX) - September 12 at 6:58 PM logoSurModics Has Returned 41.2% Since SmarTrend Recommendation (SRDX) (NASDAQ:SRDX) - August 26 at 10:30 AM logoSurmodics to Present at 5th Annual InvestMNt Conference on August 24 (NASDAQ:SRDX) - August 16 at 10:52 AM logo39.0% Return Seen to Date on SmarTrend SurModics Call (SRDX) (NASDAQ:SRDX) - August 11 at 10:52 AM logoSurModics, Inc. :SRDX-US: Earnings Analysis: Q3, 2016 By the Numbers : August 10, 2016 (NASDAQ:SRDX) - August 10 at 8:04 PM logoSurmodics IVD Launches Breakthrough StabilBlock® Immunoassay Stabilizer (NASDAQ:SRDX) - August 1 at 12:10 PM logoEdited Transcript of SRDX earnings conference call or presentation 28-Jul-16 12:30pm GMT (NASDAQ:SRDX) - July 29 at 9:51 AM
News IconSurmodics Reports Third Quarter Fiscal 2016 Results (NASDAQ:SRDX) - July 28 at 7:50 PM
News IconSurmodics introduces advanced immunoassay stabilizer StabilBlock (NASDAQ:SRDX) - July 28 at 7:50 PM logoSurModics, Inc Q3 Profit Advances 24% (NASDAQ:SRDX) - July 28 at 7:50 PM logoSurModics posts 3Q profit (NASDAQ:SRDX) - July 28 at 8:48 AM logoSurmodics to Webcast Third Quarter 2016 Earnings Conference Call on July 28 (NASDAQ:SRDX) - July 20 at 8:05 AM logoSURMODICS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statemen (NASDAQ:SRDX) - July 13 at 4:17 PM logoInvest in These 5 Efficient Stocks for Healthy Returns (NASDAQ:SRDX) - June 29 at 8:03 AM logoMyriad Genetics Buys Sividon Diagnostics, Gains EndoPredict (NASDAQ:SRDX) - June 3 at 8:59 AM logoGNC Holdings Q1 Results Weak, Overseas Prospects Bright (NASDAQ:SRDX) - June 1 at 10:30 AM logoSurModics to Present at Jefferies Healthcare Conference (NASDAQ:SRDX) - June 1 at 8:05 AM logoSURMODICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:SRDX) - May 25 at 8:05 AM logoSURMODICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Secur (NASDAQ:SRDX) - February 22 at 5:00 PM logoSurModics to Host Virtual Shareholder Meeting on February 17 (NASDAQ:SRDX) - February 16 at 8:05 AM logoSURMODICS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:SRDX) - February 5 at 4:17 PM logoSURMODICS INC Files SEC form 8-K/A, Financial Statements and Exhibits (NASDAQ:SRDX) - February 3 at 4:15 PM logoSurModics, Inc. Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:SRDX) - February 2 at 10:34 AM logoSurModics' (SRDX) Q1 Earnings & Revenues Beat Estimates (NASDAQ:SRDX) - January 29 at 11:40 AM logoSurModics, Inc Reports 44% Rise In Q1 Profit (NASDAQ:SRDX) - January 28 at 2:15 PM logoSurModics Inc Earnings Call scheduled for 8:30 am ET today (NASDAQ:SRDX) - January 28 at 8:30 AM logoSurModics Reports First Quarter Fiscal 2016 Results (NASDAQ:SRDX) - January 28 at 8:02 AM logoSurModics posts 1Q profit (NASDAQ:SRDX) - January 28 at 7:55 AM logoSURMODICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:SRDX) - January 28 at 7:51 AM logoQ1 2016 SurModics Inc Earnings Release - Before Market Open (NASDAQ:SRDX) - January 28 at 7:07 AM logoSurModics to Webcast First Quarter 2016 Earnings Conference Call on January 28 (NASDAQ:SRDX) - January 21 at 8:15 AM logoSurModics buys design and development firm NorMedix for $14M (NASDAQ:SRDX) - January 13 at 7:06 PM logoSURMODICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Dispositio (NASDAQ:SRDX) - January 13 at 4:56 PM logoSurModics Buys NorMedix for $14M, Adjusts 2016 Outlook (NASDAQ:SRDX) - January 12 at 3:22 PM logoSurModics increases exec pay; CEO Gary Maharaj got $1.48M in 2015 (NASDAQ:SRDX) - January 12 at 12:30 PM logoSurModics sees top line as high as $64M this year, non-GAAP EPS up to $0.75 (NASDAQ:SRDX) - January 11 at 1:27 PM logoSurModics Acquires NorMedix, a Design and Development Company Focused on Minimally Invasive Catheter Technologies (NASDAQ:SRDX) - January 11 at 8:18 AM logoSURMODICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:SRDX) - January 11 at 6:02 AM logoSurModics Provides Updated 2016 Guidance (NASDAQ:SRDX) - January 8 at 7:55 AM logoSurModics to Webcast Updated Fiscal 2016 Financial Guidance Conference Call on January 8 (NASDAQ:SRDX) - January 7 at 8:22 AM logoSURMODICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws (NASDAQ:SRDX) - December 23 at 6:03 AM logoSurModics, Inc. Earnings Analysis: Q4, 2015 By the Numbers (NASDAQ:SRDX) - December 22 at 11:41 AM logoSurModics Announces Device Veteran Shawn McCormick Joins Board of Directors (NASDAQ:SRDX) - December 22 at 8:20 AM


SurModics (NASDAQ:SRDX) Chart for Wednesday, October, 26, 2016

Last Updated on 10/26/2016 by Staff